Core Points - On November 19, 2025, the company announced that its stock price had experienced a cumulative increase of over 20% in the closing price over two consecutive trading days, which is classified as an abnormal trading fluctuation according to the Shanghai Stock Exchange regulations [2] - The company is in the process of a significant asset restructuring, which involves the issuance of shares and cash payment to acquire 100% equity of Shandong Tianyi Chemical Co., Ltd. (referred to as "Tianyi Chemical") [2] - The board of directors has approved this acquisition, but it still requires approval from the company's shareholders, indicating that there are uncertainties surrounding this matter [2] - The company urges investors to be aware of trading risks in the secondary market and to make rational decisions regarding their investments [2]

股票代码：600319 股票简称：亚星化学 编号：临 2025-053 潍坊亚星化学股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●潍坊亚星化学股份有限公司（以下简称"公司"）股票价格于 2025 年 11 月 18 日、11 月 19 日连续两个交易日收盘价格涨幅偏离值累计超过 20%，根据上 海证券交易所的相关规定，属于股票交易异常波动情形。 ●经公司董事会自查及发函问询控股股东、实际控制人，截至本公告披露日， 公司不存在应披露而未披露的重大信息。公司正在推进以发行股份及支付现金购 买山东天一化学股份有限公司（以下简称"天一化工"）100%股权的重大资产重 组事项，该事项已经公司董事会审议通过，尚需经公司股东会审议，相关事项尚 存在不确定性。公司敬请广大投资者注意二级市场交易风险，理性决策，审慎投 资。 一、股票交易异常波动的具体情况 公司股票于 2025 年 11 月 18 日、11 月 19 日连续两个交易日内日收盘价格 涨幅偏离值累计超过 20%，根据《上海证券交 ...

Core Viewpoint - The company announced that its stock price experienced an abnormal fluctuation, with a cumulative increase of over 20% in closing prices over two consecutive trading days [1] Group 1: Company Operations - The company's daily operations are reported to be normal, with no significant changes in the market environment or industry policies [1] - The company is advancing a major asset restructuring plan to acquire 100% of Tianyi Chemical through a combination of issuing shares and cash payments, which has been approved by the board of directors and is pending shareholder approval [1] Group 2: Disclosure and Verification - The company conducted a self-examination and verified with its controlling shareholder, confirming that there are no undisclosed significant matters affecting the abnormal stock price fluctuation, aside from information already disclosed in designated media [1]

Core Viewpoint - The company announced that its stock price experienced an abnormal fluctuation, with a cumulative increase of over 20% on November 18 and 19, 2025, indicating unusual market activity [1] Group 1: Company Operations - The company confirmed that its daily operations are normal and that there have been no significant adjustments in the market environment or industry policies [1] - The company is advancing a major asset restructuring plan involving the acquisition of 100% equity in Tianyi Chemical through a combination of stock issuance and cash payment, which has been approved by the board and is pending shareholder approval, indicating some uncertainty [1] Group 2: Stock Trading and Investor Advisory - The company stated that no significant information affecting the stock price was found during this period, and relevant personnel did not engage in buying or selling the company's stock [1] - The company reminded investors to be cautious regarding trading risks [1]

Core Insights - The chemical raw materials sector experienced a rise of 0.86% on November 19, with Huarong Chemical leading the gains [1] - The Shanghai Composite Index closed at 3946.74, up 0.18%, while the Shenzhen Component Index closed at 13080.09, unchanged [1] Stock Performance - Huarong Chemical (301256) saw a closing price of 13.74, with a significant increase of 20.00% and a trading volume of 547,600 shares, amounting to a transaction value of 710 million yuan [1] - Hengguang Co. (301118) closed at 31.58, up 19.98%, with a trading volume of 104,700 shares [1] - Yinglite (000635) closed at 10.29, increasing by 10.05% with a trading volume of 153,700 shares [1] - Other notable performers include Yaxing Chemical (10.77, +10.01%) and Qiangjian Chemical (14.21, +9.98%) [1] Fund Flow Analysis - The chemical raw materials sector saw a net outflow of 321 million yuan from institutional investors, while retail investors contributed a net inflow of 511 million yuan [2] - Huarong Chemical had a net inflow of 14.7 million yuan from institutional investors, while retail investors experienced a net outflow of 86.88 million yuan [3] - Hydrogen Alkali Chemical (600618) had a net inflow of 13.9 million yuan from institutional investors, with retail investors also seeing a net outflow [3]

Core Viewpoint - Yaxing Chemical announced plans to acquire 100% equity of Shandong Tianyi Chemical through a combination of share issuance and cash payment, which will enhance its product offerings and overall competitiveness [1] Group 1: Acquisition Details - The acquisition will add bromine series fine chemical products to Yaxing Chemical's portfolio, including tetrabromobisphenol A, brominated epoxy resin, brominated polystyrene, decabromodiphenyl ether, and hydrobromic acid [1] - The transaction will also incorporate products from Tianyi Chemical's new materials, potassium salt, and membrane materials sectors, thereby improving product layout [1] Group 2: Financial Impact - The implementation of this transaction is expected to increase the asset scale, operating income, and net profit of Yaxing Chemical, contributing to diversified revenue sources and reduced overall operational risks [1] - The acquisition aims to optimize business layout and enhance sustainable development capabilities, ultimately improving the company's competitiveness [1]

Group 1 - The chlor-alkali sector experienced a short-term surge, with Aystar Chemical hitting the daily limit up [1] - Other companies in the sector, including Shilong Industrial, Chlor-alkali Chemical, Tianyuan Co., Binhua Co., and Yinglite, also saw significant increases in their stock prices [1]

Core Viewpoint - Yaxing Chemical's stock reached the daily limit on November 18, closing at 9.79 yuan, driven by significant asset restructuring and positive project developments [1] Group 1: Major Factors Driving Stock Performance - Significant asset restructuring: The company plans to acquire 100% of Tianyi Chemical through a combination of share issuance and cash payment, with Tianyi being the largest domestic producer in the brominated flame retardant sector, holding over 50% market share in core products, thus creating complementary industrial chains [1] - New material project launch expectations: A high-end new material PVDC project with an annual capacity of 45,000 tons is nearing completion and is expected to start operations in the fourth quarter, projected to generate an additional annual revenue of 680 million yuan [1] - Non-public offering support: The fundraising plan has received participation from the controlling shareholder Weifang City Investment, with state-owned shareholders providing financial and resource support [1] - Industry landscape optimization: Amid rising dependence on imported bromine, the integration of the target company's technological barriers and market share is expected to enhance long-term competitiveness [1]

中国经济网北京11月18日讯 亚星化学(600319.SH)今日复牌，股价一字涨停，截至发稿报9.79元， 上涨10.00%，总市值37.96亿元。 亚星化学昨晚披露的发行股份及支付现金购买资产并募集配套资金暨关联交易预案显示，本次交易 中，亚星化学拟通过发行股份及支付现金的方式购买天一控股等24名股东持有的天一化学100%股权。 本次交易完成后，上市公司将持有天一化学100%股权。 标的资产的最终交易价格将以符合《证券法》规定的资产评估机构出具并经有权国有资产监督管理 部门备案的评估报告的评估结果为基础，经交易各方充分协商确定。标的资产相关审计、评估工作完成 后，上市公司将与交易对方另行签署正式协议，对最终交易价格和交易方案进行确认，并在重组报告书 中予以披露。 截至预案签署日，本次交易标的资产的审计、评估工作尚未完成，本次交易的具体交易价格尚未确 定。标的资产的交易价格将以符合法律规定的评估机构出具的并经有权国有资产监督管理部门备案的资 产评估报告确定的评估结果为基础，由交易双方协商确定，并在重组报告书中予以披露。 经交易各方友好协商，本次交易发行股份购买资产的发行价格为5.83元/股。 同时，上市公司拟 ...

最亲 ○ 单季度 11月17日晚间，亚星化学发布公告称，公司股票于11月18日开市起复牌。截至11月18日9时45分，公司股票开盘后涨停封板报9.79元/股，今年来股价已翻 倍。 | 交易类型 | 交易对方名称 | | --- | --- | | 发行股份及支付现金购买资产 | 山东天一控股集团股份有限公司等24 名山东天 | | | 一化学股份有限公司股东 | | 募集配套资金 | 包括潍坊市城市建设发展投资集团有限公司在内 | | | 的不超过 35 名符合条件的特定对象 | 截至本预案签署日，本次交易的审计及评估工作尚未完成，标的资产估值及定价尚未确定。本次交易预计将达到《重组管理办法》规定的重大资产重组标 准，构成上市公司重大资产重组。 亚星化学表示，交易完成后，公司的主要产品将新增溴系列精细化工产品，包括四溴双酚A、溴化环氧树脂、溴化聚苯乙烯、十溴二苯乙烷、氢溴酸等，以 及标的公司新材料板块、钾盐板块、膜材料板块的各项产品。 值得一提的是，本次交易构成关联交易。本次发行股份及支付现金购买资产交易对方之一华潍人才系公司控股股东潍坊市城投集团权属企业，同时本次募集 配套资金的认购方包括公司控股股东潍坊市 ...